Covered recipient · General Payments record
ROBERT JOHNSTON
Allopathic & Osteopathic Physicians Family Medicine
General Payments · PY2018–2024
$1,997.38
- Reported across 128 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $322.57 | 17 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Novo Nordisk AS | $86.85 | 4 |
| Lilly USA, LLC | $71.80 | 4 |
| ABBVIE INC. | $55.05 | 3 |
| Acerta Pharma LLC | $32.41 | 2 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $21.05 | 1 |
| DEXCOM, INC. | $20.12 | 1 |
| Xeris Pharmaceuticals, Inc. | $20.07 | 1 |
| BOSTON SCIENTIFIC CORPORATION | $15.22 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (17)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $19.32 | 07/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104005282 | CMS |
| ABBVIE INC. | $15.60 | 08/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104005284 | CMS |
| ABBVIE INC. | $20.13 | 09/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104005286 | CMS |
| AstraZeneca Pharmaceuticals LP | $18.57 | 08/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105757559 | CMS |
| AstraZeneca Pharmaceuticals LP | $13.84 | 11/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104238831 | CMS |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $21.05 | 11/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117934633 | CMS |
| Boston Scientific Corporation | $15.22 | 02/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1092349733 | CMS |
| Dexcom, Inc. | $20.12 | 08/28/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1153331543 | CMS |
| Lilly USA, LLC | $15.73 | 06/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135370128 | CMS |
| Lilly USA, LLC | $23.04 | 06/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135392825 | CMS |
| Lilly USA, LLC | $16.52 | 10/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135392153 | CMS |
| Lilly USA, LLC | $16.51 | 10/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135367700 | CMS |
| Novo Nordisk Inc | $18.12 | 02/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1097186931 | CMS |
| Novo Nordisk Inc | $22.18 | 03/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1097820958 | CMS |
| Novo Nordisk Inc | $21.75 | 05/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1097613980 | CMS |
| Novo Nordisk Inc | $24.80 | 07/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1096609286 | CMS |
| Xeris Pharmaceuticals, Inc. | $20.07 | 07/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1144610918 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2020, 2021, 2022, 2023, 2024
- Source files
- Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.